About Amanda Bonello
I provide an independent view of the GLP-1 industry.
My perspective combines direct patient experience with continued involvement across healthcare, research, advocacy, media, community, and business.
I help organizations understand how those areas connect and what they may mean for patient experience, access, communication, and strategic decisions.
Advocacy and Public Record
I mobilized patients around GLP-1 access.
- 27,000+Verified petition signatures
- 400+Public comments
- FDAAccess & compounding submissions
- USPTOPatent & competition submission
- MediaNational & international coverage
Media Coverage
Reporting that brought patient concerns to a wider audience.
Journalists have contacted me for patient and advocacy perspectives on affordability, insurance coverage, compounded medications, regulatory changes, and the consequences of losing treatment access.
My perspective comes from experiencing GLP-1 treatment directly and staying in continuous conversation with patients, clinicians, researchers, and organizations across the industry.
GLP-1 Studio
Two years solving problems in the GLP-1 space independently.
For the past two years I have worked independently on the problems patients and organizations face across the GLP-1 industry — building a growing ecosystem of focused platforms and using what I learn to help organizations make better decisions.
Recent guests
- Dr. Craig Primack, Head of Weight Loss at Hims & Hers
- Tahir Amin, Co-Founder and Co-Executive Director of I-MAK
- Jesse Kesner, Co-Founder of Alnu Health
- Justin Silver, Founder of SymptoGuard
- Aja Beckett, Founder of Shotsy
- Sabina Hemmi, Founder of GLP Winner
- Omar Al-Midani, Co-Founder of PureWay Compliance
GLP-1 Studio Podcast
Conversations with patients and the people influencing the industry.
The GLP-1 Studio Podcast features patients, founders, clinicians, researchers, advocates, and brands discussing treatment, access, innovation, policy, patient experience, and the decisions affecting obesity care.
The podcast has also documented individual access problems and broader developments affecting affordability, insurance coverage, compounding, and treatment continuity.
Top 10% Globally
Ranked #8 among GLP-1 podcasts. Source: Listen Notes, as of August 2026.
Across the Industry
Where my perspective comes from.
I gather insight from several parts of the GLP-1 industry. Select a source to see what it contributes.
Patients and Community
What I learn
What patients actually experience — expectations, side effects, cost pressure, stigma, and the reasons they start, continue, or stop treatment.
Why it matters
Patient reality is often very different from how organizations describe it.
Examples
How it informs my advisory
It grounds strategy and messaging in how patients actually think and decide.
Background and Current Roles
What I bring to advising.
Advisory and Media
- Independent GLP-1 Industry Advisor
- Founder of GLP-1 Studio
- Host of the GLP-1 Studio Podcast
- Public speaker
Patient and Public Engagement
- Founder of GLP-1 Collective, a separate 501(c)(3) nonprofit
- GLP-1 access advocate
- Patient educator
Professional Training
- ACE Certified Health Coach
- Weight Management Specialist
- Advanced education in anti-obesity medications
Bring an independent GLP-1 perspective into your next decision.
Tell me about your organization, the issue you are evaluating, and the type of guidance you need.